中国寄生虫学与寄生虫病杂志 ›› 2012, Vol. 30 ›› Issue (4): 5-274-278.

• 论著 • 上一篇    下一篇

两种尘螨1类变应原嵌合基因的原核表达及生物活性鉴定

郭伟,姜玉新,李朝品*   

  1. 皖南医学院医学寄生虫学教研室,芜湖 241002
  • 出版日期:2012-08-30 发布日期:2012-10-26

Prokaryotic Expression of Chimeric Gene Derived from the Group 1 Allergens of Dust Mites and Bioactivity Identification

GUO Wei, JIANG Yu-xin, LI Chao-pin*   

  1. Department of Medical Parasitology, Wannan Medical College, Wuhu 241002, China
  • Online:2012-08-30 Published:2012-10-26

摘要: 目的  原核表达尘螨1类变应原(粉尘螨1类变应原Derf1和户尘螨1类变应原Derp1基因)的嵌合基因R8,并检测其生物活性。  方法  以含嵌合基因R8的pUCm-T重组质粒为模板,用Derf1的特异性引物进行PCR扩增,产物经酶切后与载体pET28a(+)连接,连接产物转入大肠埃希菌(E. coli)BL21感受态细胞,并用异丙基-β-D-硫代半乳糖苷(IPTG)诱导表达后纯化,十二烷基磺酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)检测;纯化后的蛋白用ELISA检测其与粉尘螨过敏患者血清(IgE)的结合能力,同时以重组rDer f 1和rDer p 1蛋白作为对照。为检验嵌合蛋白R8的免疫原性,将75只BALB/c小鼠随机均分为5组,分别为PBS组(阴性对照组)、rDer f 1组、rDer p 1组、R8组和哮喘组(阳性对照组)。除PBS组外,其余各组分别于第0、7和14天每鼠腹腔注射(0.1 μg/μl)粉尘螨注射液100 μl,第21~27天每鼠每天雾化吸入0.5 μg/ml粉尘螨注射液悬浊液,30 min/d。rDer f 1组、rDer p 1组和R8组于第25~27天雾化前30 min,分别腹腔注射100 μg/ml的rDer f 1、rDer p 1和R8蛋白各200 μl进行特异性免疫治疗,PBS组用等量PBS进行腹腔注射和雾化吸入。所有小鼠于第27天雾化吸入后24 h气管切开,用1 ml PBS进行肺泡灌洗,收集肺泡灌洗液(BALF),检测γ干扰素(IFN-γ)和白细胞介素4 (IL-4)的水平。  结果   SDS-PAGE结果显示,R8表达产物的蛋白相对分子质量(Mr)约为35 000。ELISA检测结果显示,嵌合蛋白R8与粉尘螨过敏患者血清IgE的结合力为(37.03±12.46)μg/ml,显著低于rDer f 1[(80.44±15.50)μg/ml]和rDer p 1[(90.79±10.38)μg/ml](P<0.01)。动物实验结果显示,R8组IFN-γ水平[(343.43±38.79)pg/ml]与rDer f 1组[(322.98±30.36) pg/ml]和rDer p 1组[(314.97±33.89) pg/ml]的相比,差异均无统计学意义(P>0.05);与PBS组[(393.93±50.68)pg/ml]和哮喘组[(208.44±46.11)pg/ml]相比,差异均有统计学意义(P<0.01)。R8组IL-4水平显著低于其他各组水平(P<0.05或0.01)。  结论  表达了具有低变应原性和高免疫原性的尘螨1类变应原嵌合基因R8。

关键词: 粉尘螨, 户尘螨, 1类变应原, 嵌合基因, 原核表达, 变应原性, 免疫原性

Abstract: Objective   To express a chimeric gene R8 derived from the group 1 allergens of dust mites using prokaryotic expression system and detect their bioactivities.  Methods  PCR amplification was performed using specific primers of Derf1 gene and the pUCm-T recombinant plasmid containing the R8 chimeric gene as a template. The PCR products were inserted into the pET28a(+) empty vector after double digestion using restriction endonuclease BamHⅠ and XhoⅠ, respectively. The recombinant plasmid was transferred into E. coli line BL21 and induced by 1 mmol/L isopropyl-β-D-1-thiogalactopyranoside (IPTG). The expressed product was detected by SDS-PAGE and the target protein was purified. IgE binding assay of the purified protein R8 was detected by ELISA using dust mite allergic patient sera. For determining immunogenicity of R8 protein, 75 BALB/c mice were randomly divided into 5 groups, namely PBS (negative control), rDer f 1 group and rDer p 1 group (positive groups), R8 group and asthma group. The mice were treated with dust mite extract at 0, 7, 14 day by intraperitoneal injection of allergens (100 μl, 0.1 μg/μl) and inhaled challenge as aerosol (0.5 μg/ml, 30 min/d) on day 21 for 7 days. Before inhalation in immunotherapy groups at 25~27 day, specific allergen immunotherapy was performed using rDer f 1, rDer p 1 and R8 allergens respectively. Mice in negative control group were treated with PBS all the time. Twenty-four hours after the last challenge, mice in every group were sacrificed. The bronchoalveolar lavage fluid (BALF) was collected. ELISA was used to detect the level of interferon-γ (IFN-γ) and interleukin 4 (IL-4) in BALF.  Results   SDS-PAGE analysis revealed that chimeric gene R8 was expressed with a band of approximately Mr 35 000. Compared with groups of rDer f 1 and rDer p 1 [(80.44±15.50) and (90.79±10.38) μg/ml, respectively], IgE binding capacity of the protein R8 (37.03±12.46) μg/ml was statistically lower (P<0.001). The level of IFN-γ in sera of R8 group [(343.43±38.79) pg/ml] was higher than that of the PBS and asthma groups [(393.93±50.68) and (208.44±46.11) pg/ml, respectively] (P<0.01), but no statistical difference to that of the rDer f 1 and rDer p 1 groups (P>0.05). IL-4 level in R8 group was lower markedly than the others (P<0.05 or P<0.01). Conclusion   Chimeric protein R8 derived from the group 1 allergens of dust mites has been expressed with low allergenicity and high immunogenicity.

Key words: Dermatophagoides farinae, Dermatophagoides pteronyssinus, Group 1 allergen, Chimeric gene, Prokaryotic expression, Allergenicity, Immunogenicity